Skip to Content

VPR Cramer and Technology Commercialization staff visited the Moriarity lab, which is developing novel cellular therapeutics for genetherapy and cancer immunotherapy. Branden Moriarity and Beau Webber founded BMoGenBio, which was acuired by Bio-Techne Corporation in June 2019.